Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
about
Autophagy in malignant transformation and cancer progressionTherapeutic Targeting of AutophagyModulation of inflammation by autophagy: Consequences for human diseaseAutophagy in thyroid cancer: present knowledge and future perspectivesMolecular pathways: autophagy in cancer--a matter of timing and context.The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylationDecreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.Is BECN1 a Target Gene of Chromosome 17q21 Alteration in Breast Cancer?Beclin 1 regulates growth factor receptor signaling in breast cancer.Beclin orthologs: integrative hubs of cell signaling, membrane trafficking, and physiologyAutophagy regulation in the development and treatment of breast cancerMacroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacyGinsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagyThe Vacuolar ATPase a2-subunit regulates Notch signaling in triple-negative breast cancer cellsCombined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.DCAF4L2 promotes colorectal cancer invasion and metastasis via mediating degradation of NFκb negative regulator PPM1BThe presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.Autophagy protects ovarian cancer-associated fibroblasts against oxidative stress.Recent insights into the function of autophagy in cancer.Identification of breast cancer cell subtypes sensitive to ATG4B inhibition.Genetic inhibition of autophagy promotes p53 loss-of-heterozygosity and tumorigenesis.The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.Overexpression of caveolin-1 reduces Taxol resistance in human osteosarcoma cells by attenuating PI3K-Akt-JNK dependent autophagy.The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapy.Cellular stress response mechanisms as therapeutic targets of ginsenosides.GABARAPL1 tumor suppressive function is independent of its conjugation to autophagosomes in MCF-7 breast cancer cells.Autophagy and Inflammatory Response in the Tumor Microenvironment.Autophagy and cancer - insights from mouse models.Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against Aβ1-42-Induced Neurotoxicity and Cognitive Deficits.TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF‑κB/GLUT‑4.Increased autophagy blocks HER2-mediated breast tumorigenesis.Autophagy, Metabolism, and Cancer.
P2860
Q27000191-E50B8E0B-A9B2-40BC-937B-D08EF55D9818Q28078117-3E818ADE-1313-4C3D-9B94-9D2E55AC8D99Q28082840-8CAF2B7D-CEE0-4251-8B40-0A8BCCB412C9Q28086785-62DAFBD5-A03E-4BAD-B380-4292862F88F7Q35044465-C636879B-42BA-450B-850A-C28BD629A517Q35111525-8F053542-866D-4D6B-824B-3F4028879EECQ35223716-A432DECD-CA6B-4382-98BD-8F600478D906Q35797713-4A1EEDA7-2759-4146-881A-85F74032B21BQ35909080-9A17FDE3-DBC3-4895-87D3-D52FE31D6E49Q36011788-D8CE1641-D649-43A6-AE35-E648CEE7418DQ36398762-F8BF53DB-B083-479D-9644-E561B7FA9B59Q36459468-718033A7-8DF5-41C0-B59E-6AC42D184AADQ36499805-3755393A-3E4D-4EB1-848B-3FA18DF19968Q36544052-28DCC5A7-ADA4-440E-B45F-2CE12A0CB947Q36777278-D475BF81-ABA0-420E-B16D-12C9FA81F830Q36841120-083379F3-0ECB-4120-8CD7-89B46AF8A781Q36862687-E2719E72-6044-48D2-BC32-54E02FB6077AQ36956962-C0B5619B-3D23-49FE-B310-43665ED92025Q37343004-52290F1F-625E-4E16-912B-1766941337EDQ37687104-4F9A884D-BAD5-42FD-A707-83947FB86C54Q37708727-E7C46CA8-26B9-4553-B576-60D87E9AE182Q38584313-404C744D-3D07-45CE-A53A-315FE78CC614Q38756385-EB8A0591-E416-47D1-806E-53D2F1FE6E64Q38791390-8B58848F-E013-48F3-B221-F2F4DB17974AQ39278658-DE15F7E5-D236-4FDE-ADE2-E906C16CEAAEQ39354303-80235E57-FB3F-4C27-BD38-0DD60C7A4F41Q41348205-AE6B8A72-EE53-40C9-BB1E-6280F611A5F2Q41660244-12FA09FD-8270-4A9E-B93E-2AD0BC7EB37DQ41911940-A7088734-9A5C-42D2-9394-0CB752C53295Q41912749-4DCE7D29-BA33-4DB1-927A-C05974A0E406Q45809932-DA2DF633-8EA2-49B0-9E36-0CB636BB753DQ47243874-F1C2CCD8-971A-4E13-9BD9-A06ADFDF6DDCQ47749706-181FCEBE-A1D4-4D7D-B4EE-B863971DA49DQ52611925-CD59FD43-453E-4E61-8248-E7A3639C82A7Q53210815-1AB30BAE-6D3A-48B3-B3C0-A2E1061AB21D
P2860
Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Autophagy regulator BECN1 supp ...... tivation and following parity.
@ast
Autophagy regulator BECN1 supp ...... tivation and following parity.
@en
type
label
Autophagy regulator BECN1 supp ...... tivation and following parity.
@ast
Autophagy regulator BECN1 supp ...... tivation and following parity.
@en
prefLabel
Autophagy regulator BECN1 supp ...... tivation and following parity.
@ast
Autophagy regulator BECN1 supp ...... tivation and following parity.
@en
P2093
P2860
P356
P1433
P1476
Autophagy regulator BECN1 supp ...... tivation and following parity.
@en
P2093
Alexei Vazquez
Michelle Cicchini
Ritu Nahar
Rumela Chakrabarti
Sameera Kongara
Sandy Price
Vassiliki Karantza
Yibin Kang
P2860
P304
P356
10.4161/AUTO.34398
P577
2014-10-30T00:00:00Z